Sakar Cost Of Revenue from 2010 to 2024
| SAKAR Stock | 297.95 8.15 2.81% |
Cost Of Revenue | First Reported 2015-03-31 | Previous Quarter 325 M | Current Value 334.7 M | Quarterly Volatility 84 M |
Check Sakar Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sakar Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 188.5 M, Selling General Administrative of 207.7 M or Selling And Marketing Expenses of 447.4 K, as well as many indicators such as . Sakar financial statements analysis is a perfect complement when working with Sakar Healthcare Valuation or Volatility modules.
Sakar | Cost Of Revenue |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Sakar Stock
Sakar Healthcare financial ratios help investors to determine whether Sakar Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sakar with respect to the benefits of owning Sakar Healthcare security.